A comparative study of anxiogenic effects of fluoroquinolones in rats

Indian Journal of Physiology and Pharmacology

Volumn 42, Issue 1, 1998, Pages 135-138

  Prabhu, S ^a   Rewari, Shalini ^a  

^a MAULANA AZAD MEDICAL COLLEGE   (India)

Author keywords

Anxiogenic; Ciprofloxacin; Elevated plus maze; Ofloxacin; Pefloxacin

Indexed keywords

CIPROFLOXACIN; DRUG VEHICLE; OFLOXACIN; PEFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANIMAL EXPERIMENT; ANXIETY; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; FEMALE; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MAZE TEST; NONHUMAN; RAT;

ANIMALS; ANTI-INFECTIVE AGENTS; ANXIETY; CIPROFLOXACIN; FEMALE; INJECTIONS, INTRAPERITONEAL; MALE; OFLOXACIN; PEFLOXACIN; RATS;

EID: 0031744849     PISSN: 00195499     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Wolfson JS. Overview of fluoroquinolone safety. Am J Med 1991; 91 (Suppl 6A) : 153-161.
2. Halkin. Adverse effects of fluoroquinolones. Rev Inf Dis 1988; 10 (1) : 258-261.
3. Janknecht R. Fluoroquinolones. Adverse reactions during Clinical trials and post marketing surveillance. Pharmaceutisch Weekblad (Scientific Edition) 1989; 11: 124-127.
4. Christ W. Central nervous system toxicity of quinolones : human and animal findings. J Antimicrob Chemother 1990; 26 (B) : 219-225.
5. Rollof J, Virige E. Neurologic adverse effects during concomitant treatment with ciprofloxacin, NSAIDS and chloroquin : Possible drug interaction. Ann Pharmacother 1993; 27 (9) : 1058-1059.
6. Christ W, Lehnert T, Ulbrich B. Specific toxicologie aspects of the quinolones. Rev Inf Dis 1988; lOCSuppl I): S141-146.
7. Fellow S, Chopin P, File SE, Briely M. Validation of Open : Closed arm entries in an elevated plus maze as a measure of anxiety in rat. J Neurosci Methods 1985; 14: 149-167.
8. Leucet JC, Telly T, Lerebours G. Neurological toxicity related to pefloxacin. J Antimicrob Chemother 1988; 21: 811-820.
9. Fellow S, File SL. Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus maze. A novel test of anxiety in the rat. Biochem and behaviour 1986; 24: 525-529.
10. Akahane K, Sekiguchi M, Une T, Osada Y. Structure epileptogenicity of relationship of quinolones with special reference to their interaction with gamma-aminobutyric acid receptor sites. Antimicrob agents chemother 1989; 33: 1704-1708.
11. Unseld LE, Ziegler G, Gemerhardt A, Janssen U, Koltz U. Possible interaction of fluoroquinolones with benzodiazepine GABAA receptor complex, Br J Clin Pharmacol 1990; 30: 63-70.
12. Halliwel RF, Davey PG, Lambert JJ. The effects of quinolones and NSAIDS upon GABA evoked currents recorded from rat dorsal root ganglion neurons. J Antimicrob Chemother 1991; 27: 209218.
13. Squires RF, Saederup E. Indomethacin/ibuprofen like anti inflammatory agents relatively potentiate the gamma aminobutyric acid antagonistic effects of several norfloxacin like quinolone antibacterial agents on [35S]tbutylbicyclophosphorothionate binding. Mol Pharmacol 1993; 43(5) : 795-800.